Benign
Multiple submitters
Classification
Benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 5 submitters
gnomAD v4.1
Common
common (popmax 24.6%, amr) — too common for a highly-penetrant pathogenic allele
Conditions
1
Finnish type amyloidosis
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | <0.2 | no splice effect predicted · four deltas, not one · how we know |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP -6.7 | GERP -3.8 |
| Overall | ||
| CADD | 1.532 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
gnomAD v4.1 · exomes + genomes
Grpmax group
24.6%
Admixed American · 14,738/60,002 alleles
Filtering AF
24.2%
ClinGen BA1/BS1 input
FAF95, joint · FAF99 24.1%
Overall
3.29%
53,165/1,613,976 alleles · common
exomes 42,298/1,461,804 · genomes 10,867/152,172 · joint denominator
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Admixed Americangrpmax | 24.6% | 4 |
| East Asian | 14.9% | 7 |
| African / African-American | 14.8% | 7 |
| South Asian | 6.85% | 15 |
| Remaining individualsnot grpmax-eligible | 3.81% | 26 |
| Finnishnot grpmax-eligible | 2.78% | 36 |
| Ashkenazi Jewishnot grpmax-eligible | 2.43% | 41 |
| Middle Eastern | 1.63% | 61 |
| European (non-Finnish) | 0.801% | 125 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- GSN
- Protein
- p.Phe705=
- Coding
- c.2115T>C
- MANE Select
- NM_198252
- dbSNP
- rs9102
- Type
- single nucleotide variant
- Location
- chr9:121332522 (GRCh38)
- Gene constraint
- LOEUF 0.788 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 89.76 · 65 PDB
- Residue 705
- the 'actin-binding, ca-sensitive' region
Disease context
Finnish type amyloidosis — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor AGel amyloidosis (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- Adult
Similar variants
- GSN p.Asn160Lys Pathogenic ★★ same condition
- GSN p.Asp163Asn Pathogenic/Likely pathogenic ★★ same condition
- GSN p.Asp163Tyr Pathogenic/Likely pathogenic ★★ same condition
- GSN c.1762+2T>C Uncertain significance ★★ same condition
- GSN c.513+1G>A Uncertain significance ★★ same condition
- GSN c.753+1G>A Uncertain significance ★★ same condition
- GSN c.754-1G>T Uncertain significance ★★ same condition
- GSN c.-9-1981C>T Uncertain significance ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/gsn-p-phe705 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown